ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
---|---|---|---|---|
4985 | GFISEADQSRLTSL | S | 505 | |
4986 | NSAAVTVSS | T | 532 | |
4987 | NSAAVTVSS | S | 534 | |
4988 | NSAAVTVSS | S | 535 | |
10001220 | NSTLNSAAVTVSS | T | 10 | 532 |
10001221 | NSTLNSAAVTVSS | S | 12 | 534 |
10001604 | 535 | |||
10002968 | 532 | |||
10005675 | NSTLNSAAVTVSS | T | 10 | 532 |
10011960 | KFNFARNSTLNSAAVTVSS | T | 532 | |
10011961 | NFARNSTLNSAAVTVSS | S | 534 | |
10015654 | NSTLNSAAVTVSS | S | 12 | 534 |
10021360 | 534 | |||
10026256 | NSTLNSAAVTVSS | S | 12 | 534 |
10026937 | NSTLNSAAVTVSS | T | 10 | 532 |
10028442 | NSTLNSAAVTVSS | T | 10 | 532 |
10028872 | NSTLNSAAVTVSS | S | 12 | 534 |
10030045 | NSTLNSAAVTVSS | S | 12 | 534 |
10030130 | T | 532 | ||
10032633 | NSTLNSAAVTVSS | S | 535 | |
10032944 | NSTLNSAAVTVSS | S | 12 | 534 |
10037311 | NSTLNSAAVTVSS | 534 | ||
10037469 | NSTLNSAAVTVSS | 534 |
ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
---|---|---|---|---|---|---|---|---|---|---|
4985 | MS | HTP | ambiguous | human | T cells | 29351928 | ||||
4986 | MS | HTP | ambiguous | human | T cells | 29351928 | ||||
4987 | MS | HTP | ambiguous | human | T cells | 29351928 | ||||
4988 | MS | HTP | ambiguous | human | T cells | 29351928 | ||||
10001220 | MS | HTP | unambiguous | human | HeLa cells | 20 uM GalNAz/200 uM GalNAz | 4.87804878 | 30059200 | ||
10001221 | MS | HTP | unambiguous | human | HeLa cells | 20 uM GalNAz/200 uM GalNAz | 3.921568627 | 30059200 | ||
10001604 | MS | HTP | unambiguous | human | HeLa cells | Interphase/Mitosis | 100 | 34161081 | The p value was -log10p in original paper. | |
10002968 | MS | HTP | unambiguous | human | colorectal cancer (CRC) cell lines | SW620 cells/SW480 cells | -0.938599455 | 0.001918758 | 35254053 | |
10005675 | MS | HTP | unambiguous | human | HEK 293T cells | glucose-deprived/glucose-sufficient | 0.83 | 37541260 | ||
10011960 | MS | HTP | unambiguous | human | HeLa cells | 30059200 | ||||
10011961 | MS | HTP | unambiguous | human | HeLa cells | 30059200 | ||||
10015654 | MS | HTP | unambiguous | human | HeLa cells | 31492838 | ||||
10021360 | MS | HTP | unambiguous | human | HeLa cells | 34161081 | ||||
10026256 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | ||||
10026937 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | ||||
10028442 | MS | HTP | unambiguous | human | SW480 cells | 35254053 | ||||
10028872 | MS | HTP | unambiguous | human | SW480 cells | 35254053 | ||||
10030045 | MS | HTP | unambiguous | human | SW620 cells | 35254053 | ||||
10030130 | MS | HTP | unambiguous | human | SW480 cells, SW620 cells | SW620/SW480 | -0.938599455 | 0.001918758 | 35254053 | |
10032633 | MS | HTP | unambiguous | human | MCF-7 cells | 35513511 | ||||
10032944 | MS | HTP | unambiguous | human | Jurkat cells | 35705054 | ||||
10037311 | MS | HTP | unambiguous | human | HEK 293T cells | TMG/control | -0.152003093 | 30620550 | Peptide quantification value was applied to each modification site | |
10037469 | MS | HTP | unambiguous | human | HepG2 cells | orafenib sensitive/resistant | -0.514573173 | 30620550 | Peptide quantification value was applied to each modification site |
ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
---|---|---|---|---|---|---|---|---|---|---|---|
4985 | GFISEADQSRLTSL | S | 505 | MS | HTP | ambiguous | human | T cells | 29351928 | ||
4986 | NSAAVTVSS | T | 532 | MS | HTP | ambiguous | human | T cells | 29351928 | ||
4987 | NSAAVTVSS | S | 534 | MS | HTP | ambiguous | human | T cells | 29351928 | ||
4988 | NSAAVTVSS | S | 535 | MS | HTP | ambiguous | human | T cells | 29351928 | ||
10001220 | NSTLNSAAVTVSS | T | 10 | 532 | MS | HTP | unambiguous | human | HeLa cells | 30059200 | |
10001221 | NSTLNSAAVTVSS | S | 12 | 534 | MS | HTP | unambiguous | human | HeLa cells | 30059200 | |
10001604 | 535 | MS | HTP | unambiguous | human | HeLa cells | 34161081 | The p value was -log10p in original paper. | |||
10002968 | 532 | MS | HTP | unambiguous | human | colorectal cancer (CRC) cell lines | 35254053 | ||||
10005675 | NSTLNSAAVTVSS | T | 10 | 532 | MS | HTP | unambiguous | human | HEK 293T cells | 37541260 | |
10011960 | KFNFARNSTLNSAAVTVSS | T | 532 | MS | HTP | unambiguous | human | HeLa cells | 30059200 | ||
10011961 | NFARNSTLNSAAVTVSS | S | 534 | MS | HTP | unambiguous | human | HeLa cells | 30059200 | ||
10015654 | NSTLNSAAVTVSS | S | 12 | 534 | MS | HTP | unambiguous | human | HeLa cells | 31492838 | |
10021360 | 534 | MS | HTP | unambiguous | human | HeLa cells | 34161081 | ||||
10026256 | NSTLNSAAVTVSS | S | 12 | 534 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | |
10026937 | NSTLNSAAVTVSS | T | 10 | 532 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | |
10028442 | NSTLNSAAVTVSS | T | 10 | 532 | MS | HTP | unambiguous | human | SW480 cells | 35254053 | |
10028872 | NSTLNSAAVTVSS | S | 12 | 534 | MS | HTP | unambiguous | human | SW480 cells | 35254053 | |
10030045 | NSTLNSAAVTVSS | S | 12 | 534 | MS | HTP | unambiguous | human | SW620 cells | 35254053 | |
10030130 | T | 532 | MS | HTP | unambiguous | human | SW480 cells, SW620 cells | 35254053 | |||
10032633 | NSTLNSAAVTVSS | S | 535 | MS | HTP | unambiguous | human | MCF-7 cells | 35513511 | ||
10032944 | NSTLNSAAVTVSS | S | 12 | 534 | MS | HTP | unambiguous | human | Jurkat cells | 35705054 | |
10037311 | NSTLNSAAVTVSS | 534 | MS | HTP | unambiguous | human | HEK 293T cells | 30620550 | Peptide quantification value was applied to each modification site | ||
10037469 | NSTLNSAAVTVSS | 534 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | Peptide quantification value was applied to each modification site |